January 21, 2026
SOHO Insider Hem/Onc Library Meetings / Conferences ASH 2025

ASH 2025

The 67th ASH Annual Meeting & Exposition was held on December 6-9, 2025, at Orlando’s Orange County Convention Center.

SOHO Insider
ASH 2025 Cellular Therapy Leukemia Acute Myeloid Leukemia

Dr. Gwen Nichols, of Blood Cancer United, talks financial toxicity in blood cancer care

ASH 2025 Cellular Therapy Multiple Myeloma News

Earlier lines of cilta-cel linked to better immune fitness in myeloma

hand of a lab technician holding blood tube test and background a rack of color tubes with blood samples other patients / laboratory technician holding a blood tube test
ASH 2025

Triplet therapy shows efficacy, tolerability, and transplant potential in BPDCN

Jason Westin, MD
Lymphoma Roundtable ASH 2025 Cellular Therapy Lymphoma Aggressive B-Cell Lymphomas Roundtable Discussions Video Interviews

What are the therapeutic combinations in large cell lymphoma?

Belinda Avalos at ASH 2025
ASH 2025 Cellular Therapy Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Aggressive B-Cell Lymphomas

Dr. Avalos highlights ASH 2025 takeaways, the future of blood cancer

Pan Yu Chen
ASH 2025 Myeloma

Novel protein degraders target myeloma

Loretta Nastoupil
Lymphoma Roundtable ASH 2025 Lymphoma Indolent B-Cell Lymphomas Roundtable Discussions Video Interviews

What is the 2025 treatment landscape of follicular lymphoma?

Phase 1 PROMISE Trial Updates
ASH 2025 Myeloproliferative Neoplasms Primary Myelofibrosis

Adam Mead, MD, on interim phase 1 PROMise trial results in myelofibrosis

GGM YT
Trending now ASH 2025 Myelodysplastic Syndromes

Dr. Garcia-Manero presents phase 2 ASTX030 results in MDS and other blood cancers

Pearl Van Heteren
ASH 2025 Lymphoma Aggressive B-Cell Lymphomas

Pearl van Heteren, MD, on the DALY 2-EU trial in R/R DLBCL